Introduction
Eosinophilic lung diseases are a diverse group of disorders characterized by pulmonary opacities associated with tissue or peripheral eosinophilia. The diagnosis of eosinophilic lung disease can be made if any of the following findings is present: (a) pulmonary opacities with peripheral eosinophilia, (b) tissue eosinophilia confirmed at either open or transbronchial lung biopsy, or (c) increased eosinophils in bronchoalveolar lavage (BAL) fluid (1) . A large variety of pulmonary diseases may be associated with occasional blood eosinophilia of a minor degree. These diseases include asthma; various pulmonary infections such as coccidioidomycosis, Pneumocystis jirovecii infection, and mycobacteria; some types of tumor (eg, non-small cell lung carcinoma, lymphoma, lymphocytic leukemia); collagen vascular disorders such as rheumatoid disease and Wegener granulomatosis; idiopathic pulmonary fibrosis; and Langerhans cell histiocytosis (2) (3) (4) (5) (6) . However, these conditions are not usually considered to be eosinophilic lung diseases, in which a tissue eosinophilia is by definition pathogenically significant.
The eosinophil is a polymorphonuclear leukocyte containing several eosinophil-specific proteins in cytoplasmic granules (Fig 1) . An eosinophil can serve as an end-stage effector cell but can also have specialized roles in the host defense mechanism. However, the eosinophil sometimes harms the host by releasing specific proteins that are potentially cytotoxic to tissues, resulting in pathologic processes (7) . One of these proteins is the protein that forms Charcot-Leyden crystals, the bipyramidal crystals whose presence in sputum and tissues is a hallmark of eosinophil-related disease.
Eosinophilic lung diseases are generally classified as those of unknown cause (simple pulmonary eosinophilia [SPE] , acute eosinophilic pneumonia [AEP] , chronic eosinophilic pneumonia [CEP] , idiopathic hypereosinophilic syndrome [IHS] ) and those of known cause (allergic bronchopulmonary aspergillosis [ABPA] , bronchocentric granulomatosis [BG] , parasitic infection, drug reaction), as well as eosinophilic vasculitis (allergic angiitis, granulomatosis) ( Table 1) . Some eosinophilic lung diseases are predominantly airway based, whereas others are parenchymal or a mixture of both. A new disease entity known as eosinophilic bronchiolitis, which is characterized by pathologic and radiologic findings that suggest eosinophilic bronchiolar involvement, has been reported (8) .
In this article, we discuss and illustrate the general diagnostic approach to and the characteristic clinical, histologic, and radiologic findings in the various eosinophilic lung diseases.
Diagnostic Methods
The most valuable clinical information is derived from the patient's history and from physical examination. The duration and severity of symptoms are also of critical importance. A history of asthma may raise suspicion for Churg-Strauss syndrome, ABPA, or BG. Travel history may suggest parasitic infection. A careful history of the use of prescription and illicit drugs should be obtained.
A white blood cell differential count is an essential part of the evaluation of eosinophilic lung shows numerous eosinophils (arrows), each of which has a lobulated nucleus and cytoplasm that includes specific granules. Pulmonary function tests can occasionally be useful in the evaluation of patients with unexplained pulmonary eosinophilia. Some eosinophilic lung diseases (AEP, CEP, tropical pulmonary eosinophilia) are typically accompanied by mainly restrictive ventilatory defects, whereas others (ABPA, Churg-Strauss syndrome) typically cause mainly obstructive ventilatory defects.
BAL can also be very useful in the evaluation of patients with eosinophilic lung disease. Normal BAL fluid consists of less than 1% eosinophils. Because some disorders are not accompanied by peripheral eosinophilia, BAL may provide the first (and, perhaps, the only) indication of an eosinophilic lung disease.
Patients with eosinophilic lung disease may be identified initially on the basis of pulmonary symptoms or chest radiographic abnormalities accompanied by blood or tissue eosinophilia. Diverse and nonspecific findings may also be seen at conventional chest radiography. Chest computed tomography (CT) demonstrates a more characteristic pattern and distribution of parenchymal opacities than does chest radiography. Although the characteristic CT findings are often helpful, there is still a considerable overlap of CT findings among the various eosinophilic lung diseases (9) .
Open lung biopsy may be necessary to confirm diseases such as Churg-Strauss syndrome and BG. Biopsy is generally not required for the diagnosis of ABPA, IHS, drug reactions, or parasitic infections.
Eosinophilic Lung Diseases of Unknown Cause
Simple Pulmonary Eosinophilia SPE, or Loeffler syndrome, was originally reported as a benign AEP of unknown cause characterized by migrating pulmonary opacities, increased peripheral blood eosinophils, minimal or no pulmonary symptoms, and spontaneous resolution within 1 month. In some patients, these clinical characteristics may prove to be secondary to the presence of parasites, ABPA, or drugs (10, 11) . Pathologic specimens show edema and accumulation of eosinophils in the alveolar septa and interstitium (1) .
The radiographic manifestations of SPE consist of transient and migratory areas of consolidation that typically clear spontaneously within 1 month (12) . These consolidations are nonsegmental, may be single or multiple, usually have ill-defined margins, and often have a predominantly peripheral distribution (1, 12) . High-resolution CT findings consist of ground-glass opacity or airspace consolidation involving mainly the peripheral regions of the middle and upper lung zones (Fig 2) (9) , as well as single or multiple airspace nodules with surrounding ground-glass opacity (Fig 3) (9,13) . The differential diagnosis (2) SPE in a 25-year-old man with 13.5% peripheral eosinophilia. Transverse thin-section (1-mm collimation) CT scan (lung windowing) shows consolidation and ground-glass opacity involving mainly the peripheral regions of both lower lobes. At follow-up radiography performed 10 days later, the parenchymal opacities had cleared spontaneously. (3) SPE in a 46-year-old woman with 30.1% peripheral eosinophilia. Transverse thin-section (1-mm collimation) CT scan (lung windowing) shows an airspace nodule with surrounding ground-glass opacity in the right lower lobe (arrow). At follow-up chest radiography, the nodule had disappeared.
RG f Volume 27 • Number 3 for migratory pulmonary opacities includes pulmonary hemorrhage, pulmonary vasculitis, cryptogenic organizing pneumonia, and recurrent aspiration. In patients with airspace nodules with a ground-glass-opacity halo, the differential diagnosis includes both infectious diseases (invasive pulmonary aspergillosis, mucormycosis, candidiasis) and noninfectious diseases (Wegener granulomatosis, primary and metastatic hemorrhagic tumors, bronchioloalveolar carcinoma, pulmonary lymphoma) (14) .
Acute Eosinophilic Pneumonia
AEP represents a clinical entity that is distinct from other idiopathic eosinophilic lung diseases. Diagnostic criteria include acute febrile illness of less than 5 days' duration; hypoxemia; diffuse alveolar or mixed alveolar-interstitial opacities on chest radiographs; BAL fluid consisting of more than 25% eosinophils; absence of parasitic, fungal, or other infection; prompt and complete response to corticosteroids; and no relapse after discontinuation of corticosteroids. Peripheral blood eosinophil percentages are usually normal, although they become elevated during the subsequent clinical course (1) . Unlike with blood eosinophils, a very high percentage of BAL eosinophils is characteristic of AEP (15) . Pulmonary function testing in the acute phase shows a restrictive pattern (16) . Patients respond rapidly to high doses of corticosteroids, usually within 24 -48 hours. Unlike patients with CEP, patients with AEP do not experience relapse after discontinuation of corticosteroids (16, 17) .
The cause of AEP remains unknown; however, AEP-like signs and symptoms have been reported after cigarette smoking (18, 19) or exposure to dust (20) or smoke from fireworks (21) .
The principal histologic finding in AEP is diffuse alveolar damage associated with interstitial and alveolar eosinophilia (Fig 4) (22) .
The predominant radiographic findings in AEP are bilateral reticular densities (with or without areas of patchy consolidation) and pleural effusion (Fig 4) (23,24) . The predominant patterns of parenchymal abnormality seen at CT are bilateral patchy areas of ground-glass opacity, frequently accompanied by interlobular septal thickening and sometimes by consolidation or poorly defined nodules (Figs 4, 5) (23, 24) .
The radiologic differential diagnosis for AEP includes hydrostatic pulmonary edema, adult respiratory distress syndrome or acute interstitial pneumonia, and atypical bacterial or viral pneumonia (23) . Because initial peripheral blood eosinophil counts are usually normal, however, developing a clinicoradiologic differential diagnosis for AEP is often difficult.
Chronic Eosinophilic Pneumonia
CEP is an idiopathic condition characterized by chronic and progressive clinical features and specific pathologic findings (25) . The clinical manifestation is usually insidious, and the patient experiences symptoms for an average of 7.7 months before the diagnosis is made (26) . Most patients are middle aged, and approximately 50% have asthma (27) . Women are more frequently affected than men (25) . Pulmonary function tests can be normal in mild cases but usually show restrictive defects (26) .
Peripheral blood eosinophilia is usually mild or moderate but occasionally is severe (26) . Increased serum IgE levels are seen in two-thirds of patients (28) . The erythrocyte sedimentation rate is usually elevated (26) , and peripheral blood thrombocytosis has also been reported (29) . The percentage of eosinophils in the BAL fluid is very high (30) .
Histologic examination typically shows accumulation of eosinophils and lymphocytes in the alveoli and interstitium, with interstitial fibrosis (Fig 6) (25, 26, 31 ). An organizing pneumonia pattern or an eosinophilic abscess may also be seen (31) . The essential histologic differences between AEP and CEP are related to (a) the severity of damage to the basal lamina, and (b) the amount of subsequent intraluminal fibrosis (31) .
The typical chest radiographic finding in CEP is nonsegmental peripheral airspace consolidation ("photographic negative shadow of pulmonary RG f Volume 27 • Number 3 edema") involving mainly the upper lobes (Fig 7) (25,32-34). However, this finding may be seen in less than 50% of cases (26) . CT demonstrates typical nonsegmental areas of airspace consolidation with peripheral predominance (Fig 7) (33, 35) . Less common findings include ground-glass opacities, nodules, and reticulation (Fig 6) . These less common findings predominate in the later stages of CEP (33) . CT performed more than 2 months after the onset of symptoms shows linear bandlike opacities parallel to the pleural surface (33) . Pleural effusion is observed in less than 10% of cases (25, 26, 36) .
A number of other conditions may mimic CEP at radiology, including bronchiolitis obliterans organizing pneumonia, Churg-Strauss syndrome, and Loeffler syndrome (35, 37) . Differentiation of Churg-Strauss syndrome from CEP is necessary in patients with peripheral eosinophilia and pulmonary abnormalities. At CT, CEP is characterized by the presence of homogeneous peripheral airspace consolidation, whereas in Churg-Strauss syndrome, peripheral consolidation has a tendency toward lobular distribution and, frequently, associated centrilobular nodules within the ground-glass opacity (37) . The distribution of opacities is identical to that in Loeffler syndrome, although in the latter, the pulmonary opacities are transient and shift over days, whereas untreated CEP has a more protracted course (35) .
Idiopathic Hypereosinophilic Syndrome
IHS is a rare disorder characterized by marked, prolonged idiopathic eosinophilia and by variable organ dysfunction related either to infiltration by eosinophils or secondarily to eosinophil-associated tissue damage (38) . Diagnostic criteria include persistent eosinophilia of 1500 cells per cubic millimeter for more than 6 months or death within 6 months; the absence of parasitic, allergic, or other known causes of eosinophilia; and evidence of organ involvement and multiorgan system dysfunction (38, 39) . Onset usually occurs in the third or fourth decade of life, with a malefemale ratio of 7:1 (40) . The heart and central nervous system in particular are involved. Cardiac involvement, including endocardial fibrosis, restrictive cardiomyopathy, valvular damage, and mural thrombus formation, is the most significant complication of IHS (41) . Pulmonary involvement occurs in up to 40% of patients. Most pulmonary involvement is related to cardiac failure leading to pulmonary edema. Thromboembolic disease; peripheral neuropathy; and involvement of the gastrointestinal tract, kidneys, joints, and skin have also been reported (40, 42, 43) . The BAL fluid eosinophilia can be as high as 73% (38, 44) . Histopathologic analysis of IHS demonstrates striking eosinophilic infiltration of involved organs, including the lung, with associated disruption of the architecture and areas of necrosis (Fig 8) (39) . Radiographic findings in IHS are often nonspecific and consist of focal or diffuse, interstitial or alveolar nonlobar opacities (38, 39, 44, 45) , with most pulmonary opacities being related to severe cardiac failure. Pleural effusion is seen in 50% of cases (38, 39, 44) . CT shows nodules with or without surrounding ground-glass opacity and focal or diffuse areas of ground-glass opacity (Figs 8, 9) (13,46). The radiologic differential diagnosis for IHS is the same as that for Loeffler syndrome.
Eosinophilic Lung Diseases of Known Cause Allergic Bronchopulmonary Aspergillosis
ABPA is a hypersensitivity reaction to Aspergillus antigens and is usually caused by Aspergillus fumigatus. ABPA is typically seen in patients with long-standing asthma or cystic fibrosis. It is believed that the Aspergillus-specific IgE-mediated type I hypersensitivity reaction and the specific IgG-mediated type III hypersensitivity reactions play an important role in the pathogenesis of ABPA (47) .
ABPA is usually suspected on clinical grounds, and the diagnosis is confirmed at radiology and serologic testing (48) . Diagnostic criteria include the presence of asthma, peripheral blood eosinophilia, an immediate positive skin test for Aspergillus antigens, increased serum IgE levels, and pulmonary opacity on chest radiographs. The IgE level is probably the most useful laboratory test for ABPA, since it correlates well with disease activity (49) .
Because the diagnosis of ABPA is usually made on clinical grounds, lung biopsies are rarely performed for the diagnosis. In a study of 18 pathologic specimens obtained in patients with ABPA, the most significant findings involved the bronchi and bronchioles, with bronchocentric granulomas seen in 15 specimens and mucoid impaction in 11 (50) . Other findings included granulomatous inflammation with histiocytes and lymphocytes, increased numbers of eosinophils, and exudative bronchiolitis (Fig 10) . Fungal hyphae were commonly seen without evidence of tissue invasion (Fig 10) (50) .
Patterson et al (51) divided ABPA into five stages to help guide the management of the disease: acute, remission, exacerbation, corticosteroid dependent, and fibrotic. Although radiographic findings may be normal, findings in early-stage disease typically include transient pulmonary opacities or homogeneous, tubular, gloved-finger areas of increased opacity in a bronchial distribution, usually either predominantly or exclusively involving the upper and central lungs (Fig 10a) (52-55) . These opacities are related to the plugging of airways by hyphal masses with distal mucoid impaction. Occasionally, isolated lobar or segmental atelectasis may occur (56) . In later stages, central bronchiectasis and pulmonary 
-mm collimation) CT scans (lung windowing) obtained at two levels reveal large nodules with surrounding ground-glass opacity in the left lung (arrow).
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RG f Volume 27 • Number 3 fibrosis develop. CT findings in ABPA consist primarily of mucoid impaction and bronchiectasis involving predominantly the segmental and subsegmental bronchi of the upper lobes, along with centrilobular nodules or branching linear structures (Fig 10b) (54) . In approximately 30% of patients, the impacted mucus is highly opaque or demonstrates frank calcification at CT (56) . The differential diagnosis includes other causes of mucoid impaction such as endobronchial lesions, bronchial atresia, bronchiectasis, and bronchial asthma. Mild central bronchiectasis can be seen in asthma subsequent to chronic inflammation and does not necessarily indicate the presence of ABPA (54, 57) . However, in an asthmatic patient, ABPA is strongly suggested by the presence of randomly distributed, central, moderate to severe bronchiectasis predominantly involving the upper lungs; bronchial wall thickening; and centrilobular nodules (58) . 
arrows). (b)
Thin-section (1-mm collimation) CT scan (lung windowing) demonstrates central bronchiectasis with mucus plugging (arrows), centrilobular nodules, and bronchial wall thickening involving predominantly the segmental and subsegmental bronchi of the upper lobes. (c) Photomicrograph (original magnification, ϫ100; H-E stain) of the impacted mucoid material from a bronchoscopic biopsy specimen reveals parallel rows of necrotic eosinophils and cellular debris within a mucinous background. (d) High-power photomicrograph (original magnification, ϫ400; Gomori methenamine silver stain) shows branching fungal hyphae within impacted mucus, a finding that is suggestive of Aspergillus species.
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Bronchocentric Granulomatosis
BG is a rare disorder characterized by a necrotizing granulomatous inflammation of bronchial and bronchiolar epithelium with chronic inflammatory changes in the surrounding lung parenchyma (Fig 11) (59,60) . Approximately one-third of affected patients have tissue eosinophilia and tend to have asthma, peripheral eosinophilia, fungal hyphae at biopsy, and positive sputum cultures for Aspergillus organisms (60, 61) . These patients may have a histologic component of ABPA. The remaining two-thirds of affected patients have neutrophils rather than eosinophils in the lung lesions (60,61) and do not have asthma. In nonasthmatic patients, the underlying cause of BG is often unclear.
The radiographic manifestations of BG are also nonspecific. However, there are two dominant patterns: nodular or masslike lesions (60% of cases) and pneumonic consolidations (27%) (61) . Radiographic findings are usually unilateral (73% of cases) and seen in the upper lung zones (60%). The CT manifestations of BG consist of a focal mass or lobar consolidation with atelectasis (Fig 11b) (62) . However, the imaging features are nonspecific, and histologic confirmation is required.
Parasitic Infections
Many parasites can cause pulmonary opacities with blood or tissue eosinophilia. Because the prevalence of individual parasitic infections varies from one geographic region to another, familiarity with the common parasites in one's geographic area of practice is critical to arriving at a correct diagnosis (Fig 12) .
Strongyloides stercoralis infection can be accompanied by peripheral blood eosinophilia, rash, and transient pulmonary opacities (1) . In patients with defects of cell-mediated immunity, Strongyloides hyperinfection syndrome can develop and is associated with diffuse pulmonary opacities, gram-negative sepsis, respiratory failure, and a high mortality rate (63) .
In many developing countries, Ascaris lumbricoides is the most common cause of peripheral blood eosinophilia with pulmonary opacities. A lumbricoides was responsible for the pulmonary opacities in most of Loeffler's patients (1) . Two mechanisms of pulmonary eosinophilic infiltration in parasitic infestations have been postulated: direct invasion (eg, Ascaris, Schistosoma, and Filaria species; Paragonimus westermani; Ancylostoma duodenale) and allergic reaction (Entamoeba histolytica, Toxocara canis, Clonorchis sinensis). In cases of Clonorchis infestation, immunologic stimulation from the life cycle of C sinensis in humans may cause the pulmonary opacities manifesting as single or multiple migrating nodules (Fig 13) (64) . 
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Tropical pulmonary eosinophilia is caused by the filarial worms Wuchereria bancrofti and Brugia malayi. Serum and BAL fluid contain high levels of IgE and IgG, which correlate with the disease activity (1) . Peripheral blood eosinophil counts generally exceed 3000 cells per microliter, with an average BAL fluid eosinophilia of 50%. The earliest histologic finding in tropical pulmonary eosinophilia is an influx of histiocytes into the alveolar spaces. Large numbers of eosinophils subsequently invade the alveolar and interstitial spaces, frequently forming areas of eosinophilic abscesses. In long-standing disease, pulmonary fibrosis develops (65) . Chest radiography shows fine, diffuse reticulonodular opacities in the lower lung zones (66) .
Schistosomiasis is a helminthic infection that is endemic to tropical and subtropical regions. This infection can be divided into three categories: allergic dermatitis, acute schistosomiasis, and chronic schistosomiasis. Chronic and recurrent infection develops in persons living or traveling in endemic areas. In the lungs, granuloma formation and fibrosis around the Schistosoma eggs retained in the pulmonary vasculature may result in obliterative arteriolitis and pulmonary hypertension (67) . Acute schistosomiasis is associated with primary exposure and is commonly seen in nonimmune travelers. The common CT findings in acute pulmonary schistosomiasis are small pulmonary nodules ranging from 2 to 15 mm and larger nodules with a ground-glass-opacity halo (68, 69) .
Pleuropulmonary paragonimiasis (PP) is a parasitic disease caused by P westermani. It is contracted through the ingestion of raw or partially cooked freshwater crabs or crayfish infected with the metacercaria. Diagnosis is confirmed by the presence of parasitic eggs in the sputum, pleura, or BAL fluid. Intradermal and serologic tests are also available to help diagnose PP. tion of juvenile worms and include pneumothorax or hydropneumothorax, focal airspace consolidation, and linear opacities (Fig 14) . Later findings resulting from worm cysts include thin-walled cysts, masslike consolidation, nodules, and bronchiectasis (Fig 15) . Typical CT findings in PP are a poorly marginated subpleural or subfissural
The radiologic findings correlate well with the stage of the disease (70) . Early findings are caused by the migra-nodule that frequently contains a low-opacity necrotic area, focal pleural thickening, and subpleural linear opacities leading to a necrotic peripheral pulmonary nodule (Fig 16) (71,72) . In a study of the correlation between CT and histopathologic findings in PP, the subpleural nodule was a necrotic granuloma containing multiple eggs and organizing pneumonia with granulation tissue (Fig 16) (71) . Adjacent pleural thickening was composed of fibrotic thickening with some areas of lymphocytic infiltration. Other common CT findings include adjacent bronchiectasis, areas of ground-glass opacity, and pleural effusion or pneumothorax. PP can mimic lung cancer by (Fig 17) (71,73) . Pleural and pericardial paragonimiasis without parenchymal lesions has also been reported (Fig  18) (74) . The radiologic differential diagnosis includes bacterial infections with abscess formation, vasculitis, pulmonary tuberculosis, and cryptococcosis. However, a combination of typical CT findings and a history of eating freshwater crabs or wild boar meat in endemic areas may suggest the diagnosis of PP.
Drug Reactions
A wide variety of drugs and toxic substances are important causes of pulmonary eosinophilic infiltrates. Patients with drug-induced eosinophilic lung disease can present with a variety of pathologic conditions ranging from a mild, SPE-like syndrome to a fulminant, AEP-like syndrome. There have been two significant outbreaks of drug-induced eosinophilic lung disease. The first outbreak was the toxic-oil syndrome associated with the oral ingestion of food-grade rapeseed oil contaminated with aniline derivatives (75) . The second was the eosinophilia-myalgia syndrome associated with the ingestion of L-tryptophan (76) . Cutaneous adverse drug reactions such as toxic epidermal necrolysis and DRESS (drug rash with eosinophilia and systemic symptoms) syndrome can be life threatening. Pulmonary involvement by cutaneous adverse drug reactions is rare (Fig 19) and is considered to be a severity factor (77) . Many patients with drug-induced eosinophilic lung disease will improve by simply discontinuing the medication; in severe or persistent cases, however, short courses of corticosteroids appear to hasten recovery. The diagnosis is usually made on the basis of clinical history and blood eosinophilia rather than imaging findings.
At histologic analysis, drug-induced eosinophilic pneumonia is characterized by the accumulation of eosinophils and macrophages in the alveolar spaces (78) . There is also usually an accompanying infiltrate composed of eosinophils, lymphocytes, and plasma cells within the alveolar septa and adjacent interstitium. Chest radiography demonstrates variable and nonspecific findings that include consolidation, hilar adenopathy, pleural effusion, and reticulonodular densities. CT more clearly reveals the pattern and extent of the variable findings, including areas of ground-glass opacity, consolidation, nodules, and irregular lines (Fig 20) (13) . In one series, airspace consolidation and groundglass opacity in a predominantly peripheral distribution were the most common high-resolution CT findings (79) .
Eosinophilic Vasculitis
Churg-Strauss syndrome was first described in 1951 by Churg and Strauss on the basis of the histologic criteria of tissue infiltration by eosinophils, necrotizing vasculitis, and extravascular granulomas (80) . The diagnosis of Churg-Strauss syndrome can be made if four or more of the following six findings are present: asthma, eosinophilia greater than 10% of the white blood cell differential count, neuropathy, migratory or transient pulmonary opacities, paranasal sinus abnormalities, and extravascular eosinophils revealed at biopsy (81) . The etiology of Churg-Strauss syndrome is still unknown, but an allergic or immune pathogenesis for the disease has been suggested by the presence of asthma, eosinophilia, and elevated serum IgE levels in some cases (82) . Several recent reports have suggested an association between the use of leukotriene receptor antagonists for treating asthma and Churg-Strauss syndrome (83) (84) (85) . Asthma is the central feature of Churg-Strauss syndrome. The relatively late patient age at onset distinguishes the asthma in patients with Churg-Strauss syndrome from that in the general population. Whereas asthma is often accompanied by eosinophilia that seldom exceeds 0.8 ϫ 10 9 cells per liter, the eosinophilia in Churg-Strauss syndrome is generally of a much higher order (37) .
The lung is the most commonly involved organ, followed by the skin. However, any organ can be involved, including the central nervous system, heart, and gastrointestinal tract ( Table 2) . CEP is commonly associated with asthma and tissue eosinophilia but does not manifest with granulomatous arteritis and is not associated with extrapulmonary lesions.
At radiography, Churg-Strauss syndrome usually appears as bilateral nonsegmental consolidation or reticulonodular opacities (37) . The most common thin-section CT findings include subpleural ground-glass opacity or consolidation with a lobular distribution, centrilobular nodules, bronchial wall thickening, and interlobular septal thickening (Figs 21, 22) . Less common findings include hyperinflation, mediastinal or hilar lymphadenopathy, and pleural or pericardial effusion (37, 86) . The radiologic differential diagnosis includes CEP and other types of pulmonary angiitis and granulomatosis (37) . At CT, CEP is characterized by the presence of homogeneous peripheral airspace consolidation, whereas in ChurgStrauss syndrome, peripheral consolidation has a tendency toward lobular distribution and the frequent presence of centrilobular nodules within the ground-glass opacity. Solitary or multiple nodules with frequent cavitation are the most common finding in Wegener granulomatosis, lymphomatoid granulomatosis, and necrotizing sarcoid granulomatosis; in Churg-Strauss syndrome, on the other hand, the most common finding is peripheral consolidation, with multiple nodules occurring rather infrequently (37) .
Conclusions
Patients may first be recognized as having an eosinophilic lung disease on the basis of pulmonary symptoms or chest radiographic abnormalities accompanied by an increased number of blood, (Table 3) . 
